Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$657M |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$587M |
| 4 |
AstraZeneca
AZN
|
+$319M |
| 5 |
Snowflake
SNOW
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$323M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$273M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$121M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$98.6M |
| 5 |
JD.com
JD
|
+$89.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.03% |
| 2 | Financials | 13.72% |
| 3 | Healthcare | 12.6% |
| 4 | Consumer Discretionary | 10.97% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Accel Entertainment
ACEL
$987M
| $256K | ﹤0.01% |
21,086
+11,061
| +110% | +$127K |
|
2602
iShares Core S&P 500 ETF
IVV
$902B
| $256K | ﹤0.01% |
595
-900
| -60% | -$399K |
|
2603
SkinHealth Systems
SKIN
$85.7M
| $256K | ﹤0.01% |
9,835
+4,129
| +72% | +$90.8K |
|
|
NEX
2604
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $256K | ﹤0.01% |
55,771
+31,892
| +134% | +$128K |
|
|
ENIA
2605
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
| $256K | ﹤0.01% |
43,782
| – | – |
|
|
FFIC
2606
DELISTED
Flushing Financial
FFIC
| $255K | ﹤0.01% |
11,250
+5,170
| +85% | +$114K |
|
|
RUBY
2607
DELISTED
Rubius Therapeutics, Inc
RUBY
| $255K | ﹤0.01% |
14,260
+7,884
| +124% | +$171K |
|
2608
Cass Information Systems
CASS
$743M
| $254K | ﹤0.01% |
6,080
+2,707
| +80% | +$115K |
|
2609
Zymeworks
ZYME
$1.67B
| $254K | ﹤0.01% |
8,755
+7,295
| +500% | +$243K |
|
2610
Great Southern Bancorp
GSBC
$878M
| $253K | ﹤0.01% |
4,617
+2,188
| +90% | +$116K |
|
|
TRIL
2611
DELISTED
Trillium Therapeutics Inc.
TRIL
| $253K | ﹤0.01% |
14,060
+144
| +1% | +$1.68K |
|
2612
BioXcel Therapeutics
BTAI
$27.8M
| $252K | ﹤0.01% |
520
+248
| +91% | +$109K |
|
|
DHIL
2613
DELISTED
Diamond Hill
DHIL
| $251K | ﹤0.01% |
1,428
+593
| +71% | +$104K |
|
2614
Tucows
TCX
$175M
| $251K | ﹤0.01% |
3,174
+1,795
| +130% | +$139K |
|
2615
Plains GP Holdings
PAGP
$4.9B
| $250K | ﹤0.01% |
23,208
| – | – |
|
|
RMO
2616
DELISTED
Romeo Power, Inc.
RMO
| $249K | ﹤0.01% |
50,195
+25,871
| +106% | +$155K |
|
2617
Nicolet Bankshares
NIC
$3.62B
| $248K | ﹤0.01% |
3,339
+2,252
| +207% | +$164K |
|
2618
Stoneridge
SRI
$213M
| $248K | ﹤0.01% |
12,167
+5,337
| +78% | +$132K |
|
2619
Harmony Biosciences
HRMY
$2.24B
| $246K | ﹤0.01% |
6,438
+3,340
| +108% | +$108K |
|
2620
Grupo Aeroportuario del Sureste
ASR
$8.3B
| $245K | ﹤0.01% |
1,308
| – | – |
|
2621
Anterix
ATEX
$1.94B
| $244K | ﹤0.01% |
4,018
+2,302
| +134% | +$135K |
|
2622
Immunovant
IMVT
$8.25B
| $244K | ﹤0.01% |
28,056
+7,071
| +34% | +$63.8K |
|
2623
Keros Therapeutics
KROS
$221M
| $243K | ﹤0.01% |
6,144
+2,519
| +69% | +$89.6K |
|
2624
ARKO Corp
ARKO
$635M
| $242K | ﹤0.01% |
23,938
+20,313
| +560% | +$183K |
|
2625
Bank of Marin Bancorp
BMRC
$459M
| $241K | ﹤0.01% |
6,390
+3,731
| +140% | +$130K |
|
Similar funds
Legal & General Group's Q3 2021 Portfolio in Review
As of Q3 2021, Legal & General Group held 3,551 positions worth $308B, up 2.9% from $299B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Legal & General Group deployed $10.7B of net new capital in Q3 2021, opening 77 new positions and adding to 2,293 existing holdings. Its largest new stake was AstraZeneca: 2,738,007 shares worth $329M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was JD.com, an estimated $89.3M trimmed.
- Legal & General Group's largest Q3 2021 buy was AstraZeneca: 2,738,007 shares worth $329M.
- Legal & General Group added most to Microsoft in Q3 2021, an estimated $657M increase.
- Legal & General Group's biggest Q3 2021 reduction was JD.com, cutting an estimated $89.3M.
- Legal & General Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $323M.
- Legal & General Group's ten largest holdings make up 22% of its $308B portfolio in Q3 2021.
- Legal & General Group opened 77 new positions and closed 55 in Q3 2021.
- Legal & General Group's portfolio value rose 2.9% quarter-over-quarter to $308B.
Based on Legal & General Group's 13F filing for Q3 2021, filed 15 Nov 2021.